News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,138 Results
Type
Article (8018)
Company Profile (139)
Press Release (474981)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166770)
Career Advice (306)
Deals (25740)
Drug Delivery (7)
Drug Development (52879)
Employer Resources (14)
FDA (9761)
Job Trends (8577)
News (238249)
Policy (17931)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (481)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33156)
ALS (102)
Alzheimer's disease (966)
Antibody-drug conjugate (ADC) (254)
Approvals (10339)
Artificial intelligence (310)
ASCO (159)
Autoimmune disease (196)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (104)
Biotechnology (88)
Bladder cancer (132)
Brain cancer (28)
Breast cancer (501)
Cancer (3563)
Cardiovascular disease (213)
Career advice (245)
Career pathing (1)
CAR-T (169)
Celiac Disease (1)
Cell therapy (469)
Cervical cancer (34)
Clinical research (47738)
Collaboration (1206)
Commercialization (1)
Compensation (1390)
Complete response letters (33)
COVID-19 (749)
CRISPR (62)
C-suite (707)
Cystic fibrosis (84)
Data (5507)
Denatured (4)
Depression (101)
Dermatology (59)
Diabetes (336)
Diagnostics (4153)
Digital health (36)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (145)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (158)
Earnings (73053)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87445)
Executive appointments (680)
FDA (12289)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (894)
Gene editing (123)
Generative AI (9)
Gene therapy (309)
GLP-1 (284)
Government (940)
Grass and pollen (2)
Guidances (280)
Healthcare (9308)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (60)
Immunology and inflammation (96)
Immuno-oncology (54)
Indications (151)
Infectious disease (935)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (247)
Interviews (41)
IPO (12378)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Liver cancer (43)
Longevity (15)
Lung cancer (490)
Lymphoma (242)
Machine learning (27)
Management (3)
Manufacturing (511)
Marketing (7)
MASH (116)
Medical device (8632)
Medtech (8755)
Mergers & acquisitions (14350)
Metabolic disorders (690)
mRNA (50)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (213)
Neuropsychiatric disorders (38)
Neuroscience (1786)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (219)
Opinion (10)
Ovarian cancer (156)
Pain (169)
Pancreatic cancer (191)
Parkinson's disease (196)
Partnered (11)
Patents (457)
Patient recruitment (477)
Peanut (31)
People (41119)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15429)
Phase 2 (21316)
Phase 3 (14354)
Pipeline (6661)
Policy (18)
Postmarket research (1570)
Preclinical (6526)
Press Release (34)
Prostate cancer (187)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (557)
Real estate (3019)
Recruiting (6)
Regulatory (14683)
Reports (16)
Research institute (578)
Resumes & cover letters (45)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (98)
Series A (149)
Series B (117)
Service/supplier (4)
Sickle cell disease (62)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (49)
Vaccines (311)
Venture capital (17)
Weight loss (70)
Women's health (75)
Date
Last 7 days (261)
Last 30 days (1065)
Last 365 days (19031)
2026 (10759)
2025 (19251)
2024 (22987)
2023 (26539)
2022 (34593)
2021 (37168)
2020 (33468)
2019 (23259)
2018 (17493)
2017 (18765)
2016 (17919)
2015 (24268)
2014 (21683)
2013 (18136)
2012 (20222)
2011 (20440)
2010 (20334)
Location
Africa (227)
Alabama (71)
Alaska (2)
Arizona (292)
Arkansas (11)
Asia (17843)
Australia (2090)
California (11522)
Canada (3043)
China (505)
Colorado (464)
Connecticut (390)
Delaware (203)
Europe (24573)
Florida (1716)
Georgia (364)
Hawaii (2)
Idaho (46)
Illinois (679)
India (42)
Indiana (308)
Iowa (13)
Japan (386)
Kansas (98)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1154)
Massachusetts (7585)
Michigan (299)
Minnesota (539)
Mississippi (4)
Missouri (78)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2536)
New Mexico (12)
New York (2736)
North Carolina (1228)
North Dakota (4)
Northern California (5735)
Ohio (268)
Oklahoma (14)
Oregon (14)
Pennsylvania (2192)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (75)
South Dakota (1)
Southern California (4780)
Tennessee (113)
Texas (1858)
United States (37494)
Utah (345)
Vermont (1)
Virginia (146)
Washington D.C. (38)
Washington State (893)
West Virginia (1)
Wisconsin (73)
483,138 Results for "croda inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Partnership agreement between Croda and AAHI to drive innovation in vaccine development
Croda International Plc and The Access to Advanced Health Institute are pleased to announce the signing of a partnership agreement around innovation and development of adjuvant formulations, under which Croda and AAHI will leverage their combined expertise to make novel vaccine adjuvant formulations globally accessible, thereby advancing next generation, robust and durable vaccines.
March 19, 2024
·
4 min read
Business
Croda and Botanical Solution Inc. (BSI) Announce Partnership to Accelerate Production of Sustainable Vaccine Adjuvant QS-21
Croda Pharma and BSI announced that they have entered into a strategic collaboration agreement to support the sustainable sourcing of pharmaceutical grade adjuvant QS-21, a potent component of adjuvant systems.
May 22, 2023
·
3 min read
Business
Botanical Solution Inc. (BSI) & Croda Pharma Partnership Agreement to Accelerate Production for GMP QS-21
Botanical Solution Inc. (BSI), innovator of sustainable, consistent and cost-effective Advanced Botanical Materials (ABM) for agricultural and pharmaceutical applications, has entered into a Partnership Agreement with Croda Pharma to build a robust, scalable and truly sustainable supply chain and deliver kilogram-quantities of QS-21 to the pharmaceutical industry.
November 30, 2022
·
4 min read
Policy
U.S. Government to support expansion of Croda lipid systems capability
Croda International Plc announces that it has entered into a cooperative agreement with the United States government in which the government will provide up to $75 million to expand the company’s U.S. manufacturing capacity of ingredients for lipid systems used in novel therapeutic drugs, such as mRNA vaccines.
June 28, 2022
·
5 min read
Nautilus Biosciences Officially Opens Its Expanded UPEI-Based Facility as Croda’s Centre of Innovation for Marine Biotechnology
PEI’s Nautilus Biosciences, a wholly owned subsidiary of Croda International Plc (“Croda”), celebrated its official opening today as the new Centre of Innovation for Marine Biotechnology.
October 31, 2018
·
7 min read
Deals
Avanti Polar Lipids Agrees to be Acquired by Croda
Avanti combining with Croda to expand life sciences products, pharmaceutical services and cGMP production capabilities for biotechnology, pharmaceutical and life science research customers globally Avanti will continue to operate under the Avanti brand and be led by the current management team [06-July-2020] ALABASTER, Alabama , July 6, 2020 /PRNewswire/ --
July 6, 2020
·
4 min read
Business
AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENE
Amyris, Inc. today announced that it has signed an exclusive license agreement with British specialty chemicals company Croda International Plc, or the supply of sustainable squalene.
May 19, 2023
·
5 min read
Deals
Croda Invests in SiSaf’s Novel Bio-Courier Technology
Croda has also acquired a minority shareholding in SiSaf.
August 1, 2018
·
3 min read
Press Releases
Encision Inc. Announces Start of Stock Trading
July 14, 2026
·
1 min read
Press Releases
La Jolla Labs Inc., Unravel Biosciences Inc., and Ulm University Announce Strategic Collaboration to Advance AI-Driven Therapeutics for ALS
July 16, 2026
·
1 min read
1 of 48,314
Next